Stock Taper 
ATAI
$7.29
▼ DOWN 0.82% (-0.06)
KEY STATISTICS
Market Cap$2.70 B
52w High$7.45
52w Low$3.27
Dividend Yield30.17%
FrequencySpecial
P/E-13.25
Volume2.53M
Shares Out.369.95M
COMPANY
LEADERSHIP
CHIEF EXECUTIVE
Srinivas G. Rao
COMPENSATION 2026
Salary$629,200
Stock Awards$0
Incentive Plan Pay$0
All Other Comp.$24,740
Total$4,420,555
ABOUT
SECTOR
Healthcare
WENT PUBLIC
June 18, 2021
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
99
PRICE TARGET
Target High$8.00
Target Low$7.45
Target Median$7.50
Target Consensus$7.69
UPCOMING EARNINGS
DateNov 12, 2026
DayThursday
Rev. Est.$300.00K
NOV
12
THU
PRICE
$7.29 ▼ DOWN 0.82% (−$0.06)About Atai Beckley Inc.
https://www.ataibeckley.com ↗Atai Beckley NV, a clinical-stage biopharmaceutical company founded in 2018 and based in the Netherlands, focuses on developing treatments for mental health disorders.
INDUSTRY
Biotechnology
A PRODUCT ATAI BECKLEY INC. IS KNOWN FOR
BPL-003 (mebufotenin benzoate)
BPL-003, an intranasal mebufotenin benzoate developed by AtaiBeckley, is a Phase 3-ready, FDA Breakthrough Therapy-designated treatment for treatment-resistant depression, resulting from a strategic partnership between Atai Life Sciences and Beckl...
Revenue by Products
| Icon | PRODUCT | Q4-2022 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|---|
 | License | — | $202K | $0 ▼ | $0 |
 | Research And Development Services | $0 | — | — | — |
ETFS HOLDING THIS STOCK
ETFS HOLDING
116
LISTED HERE
20
RANKED BY POSITION SIZE
INSTITUTIONAL OWNERSHIP
SHARES OWNED
25.18%
HOLDERS
299
TOP 12 OF 299 · RANKED BY POSITION SIZE
Blackrock, Inc.
Deep Track Capital, LP
State Street Corp
Ubs Group AG
Adage Capital Partners Gp, L.L.C.
Geode Capital Management, LLC
Susquehanna International Group, Llp
Morgan Stanley
Millennium Management LLC
Candriam S.C.A.
Qube Research & Technologies Ltd
Foresite Capital Management Vi LLC
RATINGS SNAPSHOT
Overall rating: C-
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity4
Price To Earnings1
Price To Book1
Overall Score1
INSIDER TRADES
★
DIRECTOR
Feilding-Mellen Cosmo
Sale · 40.4K shares
2025-11-25
★
DIRECTOR
Feilding-Mellen Cosmo
Purchase · 10.0K shares
2025-11-25
★
Feilding-Mellen Cosmo
— · —
2025-11-05
★
DIRECTOR
HERSHBERG ROBERT
Purchase · 97.7K shares
2025-11-05
MOST RECENT ANALYST GRADES
GRADE SUMMARY
HOLD 6
NEUTRAL 2
8 GRADES IN THE LAST 12 MONTHS
SECTORS PEERS
| PEER | PRICE | |
|---|---|---|
 DNTH | $105.84 | COMPARE |
 ELVN | $57.86 | COMPARE |
 RLAY | $18.77 | COMPARE |
 AMLX | $34.74 | COMPARE |
 NKTR | $72.52 | COMPARE |
 INBX | $123.41 | COMPARE |
 SNDX | $19.54 | COMPARE |
 ORIC | $13.24 | COMPARE |